Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA000697 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA000697, RRID:AB_1079621
- Product name
- Anti-PIR
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human PIR, Gene description: pirin (iron-binding nuclear protein), Validated applications: WB, Uniprot ID: O00625, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Pirin Inhibits FAS‐Mediated Apoptosis to Support Colorectal Cancer Survival
miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonizationin vivoand causes significant signaling alterations
High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer
Ma H, Suleman M, Zhang F, Cao T, Wen S, Sun D, Chen L, Jiang B, Wang Y, Lin F, Wang J, Li B, Li Q
Advanced Science 2023;11(10)
Advanced Science 2023;11(10)
miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonizationin vivoand causes significant signaling alterations
Thomsen K, Terp M, Lund R, Søkilde R, Elias D, Bak M, Litman T, Beck H, Lyng M, Ditzel H
Oncotarget 2015;6(30):29224-29239
Oncotarget 2015;6(30):29224-29239
High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer
Shubbar E, Helou K, Kovács A, Nemes S, Hajizadeh S, Enerbäck C, Einbeigi Z
BMC Cancer 2013;13(1)
BMC Cancer 2013;13(1)
No comments: Submit comment
No validations: Submit validation data